Figures computed from official regulatory filings — .
Ownershipinsiders 61.86% · institutions 0%
In USD · as of Oct 26, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Innovation1 Biotech Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Innovation1 Biotech Inc. focuses on researching, developing, producing, and selling pharmaceutical products. The company offers natural supplements for the treatment of symptoms associated with the flu and long covid under the NutraFlu and Nutravid19 brands; and other supplement and medical nutrition products. It also develops NLC001 that is in Phase II clinical trial for the treatment of long covid and other viral indications. The company is based in New York, New York.
Market information source · Oct 26, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 26, 2026
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Orr Timothy | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Orr Timothy | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |